Arhgef9 Antikörper (N-Term)
Kurzübersicht für Arhgef9 Antikörper (N-Term) (ABIN5671437)
Target
Alle Arhgef9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- DEEGWFPASF VRLWVNQEDE VEEGPSDVQN GHLDPNSDCL CLGRPLQNRD
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human ARHGEF9
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Arhgef9 (Cdc42 Guanine Nucleotide Exchange Factor (GEF) 9 (Arhgef9))
-
Andere Bezeichnung
- ARHGEF9
-
Hintergrund
-
The protein encoded by this gene is a Rho-like GTPase that switches between the active (GTP-bound) state and inactive (GDP-bound) state to regulate CDC42 and other genes. Defects in this gene are a cause of startle disease with epilepsy (STHEE), also known as hyperekplexia with epilepsy. Three transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: PEM2, EIEE8, PEM-2, HPEM-2, COLLYBISTIN
Protein Size: 516 -
Gen-ID
- 23229
-
NCBI Accession
- NM_001173479, NP_001166950
-
UniProt
- O43307
-
Pathways
- Neurotrophin Signalübertragung
Target
-